|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM187483175 |
003 |
DE-627 |
005 |
20250210072847.0 |
007 |
cr uuu---uuuuu |
008 |
231223s2009 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2009.02.008
|2 doi
|
028 |
5 |
2 |
|a pubmed25n0625.xml
|
035 |
|
|
|a (DE-627)NLM187483175
|
035 |
|
|
|a (NLM)19328743
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Schejbel, Lone
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Properdin deficiency associated with recurrent otitis media and pneumonia, and identification of male carrier with Klinefelter syndrome
|
264 |
|
1 |
|c 2009
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 09.06.2009
|
500 |
|
|
|a Date Revised 19.11.2015
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Properdin is an initiator and stabilizer of the alternative complement activation pathway (AP). Deficiency of properdin is a rare X-linked condition characterized by increased susceptibility to infection with Neisseria meningitidis associated with a high mortality rate. We report properdin deficiency in a large Pakistani family. The index cases were found by screening for immunodeficiency due to a history of recurrent infections. This revealed absent AP activity, but normal classical and lectin pathway activity. Sequencing of the properdin gene (PFC) revealed a novel frameshift mutation. When all available relatives (n=24) were screened for the mutation, four affected males, four female carriers and a male heterozygous carrier were identified. He was subsequently diagnosed with Klinefelter syndrome. A questionnaire revealed a striking association between properdin deficiency and recurrent otitis media (P=0.0012), as well as recurrent pneumonia (P=0.0017). This study is the first to show a significant association between properdin deficiency and recurrent infections
|
650 |
|
4 |
|a Case Reports
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
7 |
|a Properdin
|2 NLM
|
650 |
|
7 |
|a 11016-39-0
|2 NLM
|
700 |
1 |
|
|a Rosenfeldt, Vibeke
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Marquart, Hanne
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Valerius, Niels Henrik
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Garred, Peter
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 131(2009), 3 vom: 15. Juni, Seite 456-62
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:131
|g year:2009
|g number:3
|g day:15
|g month:06
|g pages:456-62
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2009.02.008
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 131
|j 2009
|e 3
|b 15
|c 06
|h 456-62
|